AUS
NZ
UK
CA
USA
IND
With a remarkable 289% increase in its stock price over the past year, Celestica continues to soar, prompting many investors to wonder if they’ve missed out on this explosive growth or if there’s still room for further gains. Let’s explore the factors driving Celestica’s recent performance and whether it signals a promising future for potential investors in this TSX tech stock.
Celestica, a prominent player in the electronics manufacturing services (EMS) industry, has delivered impressive financial results amid challenging market conditions. In fiscal year 2023, the company reported revenues of US$7.1 billion, marking a robust 12% year-over-year growth. This expansion was fueled by increased demand across key sectors such as aerospace, defence, and healthcare.
In the first quarter of 2024, Celestica (TSX: CLS) exceeded expectations with an earnings per share (EPS) of US$0.44, surpassing analysts’ forecasts by US$0.06. The company’s net income for the same period rose to US$56.7 million, reflecting strong operational efficiency and effective capitalization on market opportunities.
What’s behind Celestica’s impressive growth trajectory? Diversification plays a pivotal role. Beyond traditional EMS offerings, Celestica has expanded into areas like design and engineering services, supply chain management, and after-market services. This strategic diversification has not only broadened its market reach but also reduced dependency on any single revenue stream.
Moreover, Celestica’s acquisition of PCI Private Limited in Singapore has bolstered its capabilities in high-growth markets, contributing approximately US$330 million in annual revenue. This strategic move enhances Celestica’s competitive edge and reinforces its position as a leader in the EMS sector.
The company’s focus on burgeoning sectors such as aerospace, defence, and healthcare further underscores its growth strategy. With the aerospace and defence industry projected to grow at a compound annual growth rate (CAGR) of 5.6% through 2028, Celestica is well-positioned to capitalize on these expanding markets.
Despite its substantial recent gains, Celestica’s stock presents an attractive valuation opportunity. Currently trading at a forward price-to-earnings ratio of 22.91, which is lower compared to industry peers, the stock may still offer significant upside potential for investors.
Market conditions remain favorable for Celestica, with the global EMS market expected to grow at a CAGR of 7.5% over the next five years. This growth is driven by increasing product complexity and the outsourcing trend among OEMs, which positions Celestica favorably to capitalize on these industry dynamics.
While Celestica has experienced remarkable stock price appreciation, the data and market outlook suggest that the growth story is far from over. With strong financial performance, strategic expansions, and a favorable industry landscape, Celestica presents a compelling opportunity for investors seeking exposure to the thriving EMS sector.
For investors considering adding a robust performer like Celestica to their portfolio, the current valuation and growth prospects make it a promising candidate for long-term investment success. As always, prudent consideration of personal financial goals and risk tolerance is advisable before making any investment decisions.
